Patents Assigned to ASARINA PHARMA AB
  • PHARMACEUTICAL COMPOSITION COMPRISING 3-BETA-HYDROXY-5-ALPHA-PREGNAN-20-ONE WITH IMPROVED STORAGE AND SOLUBILITY PROPERTIES
    Publication number: 20230117905
    Abstract: It is provided a pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one, at least one sterol or an ester thereof and a mixture of acylglycerols with a solid fat content of less than 25% at 25° C. and 0% at 37° C. In addition it is provided a method for preparing the pharmaceutical composition.
    Type: Application
    Filed: November 17, 2022
    Publication date: April 20, 2023
    Applicant: ASARINA PHARMA AB
    Inventors: Torbjörn Bäckström, Anders Carlsson
  • Pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with improved storage and solubility properties
    Patent number: 11534446
    Abstract: It is provided a pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one, at least one sterol or an ester thereof and a mixture of acylglycerols with a solid fat content of less than 25% at 25° C. and 0% at 37° C. In addition it is provided a method for preparing the pharmaceutical composition.
    Type: Grant
    Filed: May 22, 2017
    Date of Patent: December 27, 2022
    Assignee: ASARINA PHARMA AB
    Inventors: Torbjörn Bäckström, Anders Carlsson
  • 3-beta-hydroxy-5-alpha-pregnan-20-one for use in medical treatment
    Patent number: 11026954
    Abstract: The present invention provides the steroid compound 3beta-hydroxy-5alpha-pregnan-20-one for use in treatment of Tourette's syndrome, obsessive compulsive disorder and/or gambling disorder, as well as methods for treating said disorders and pharmaceutical compositions for use in treatment of said disorders.
    Type: Grant
    Filed: September 2, 2018
    Date of Patent: June 8, 2021
    Assignee: ASARINA PHARMA AB
    Inventor: Torbjörn Bäckström
  • 3-beta-hydroxy-5-alpha-pregnan-20-one for use in treatment of essential tremor
    Patent number: 11026953
    Abstract: The present invention provides the steroid compound 3beta-hydroxy-5alpha-pregnan-20-one for use in treatment of essential tremor, as well as methods for treating essential tremor and pharmaceutical compositions for use in treatment of essential tremor.
    Type: Grant
    Filed: September 2, 2018
    Date of Patent: June 8, 2021
    Assignee: ASARINA PHARMA AB
    Inventors: Torbjörn Bäckström, Markus Jerling
  • Injectable Suspensions
    Publication number: 20210100736
    Abstract: The present invention relates to aseptic suspensions, physically stable and injectable through a 25 G needle or thinner, comprising crystalline, non-micronized 3-beta-hydroxy-5-alpha-pregnan-20-one particles, a mixture of acylglycerols and cholesterol, processes for preparing crystalline, non-micronized, 3-beta-hydroxy-5-alpha-pregnan-20-one suitable for such suspensions, as well as methods for manufacturing such suspensions.
    Type: Application
    Filed: December 15, 2020
    Publication date: April 8, 2021
    Applicant: ASARINA PHARMA AB
    Inventors: Magnus Brisander, Karol Horvath, Björn Norrlind
  • Injectable suspension comprising 3-beta-hydroxy-5-alpha-pregnan-20-one, and a method for the manufacturing thereof
    Patent number: 10933014
    Abstract: The present invention relates to aseptic suspensions, physically stable and injectable through a 25G needle or thinner, comprising crystalline, non-micronized 3-beta-hydroxy-5-alpha-pregnan-20-one particles, a mixture of acylglycerols and cholesterol, processes for preparing crystalline, non-micronized, 3-beta-hydroxy-5-alpha-pregnan-20-one suitable for such suspensions, as well as methods for manufacturing such suspensions.
    Type: Grant
    Filed: January 9, 2018
    Date of Patent: March 2, 2021
    Assignee: ASARINA PHARMA AB
    Inventors: Magnus Brisander, Karol Horvath, Björn Norrlind
  • 3-Beta-Hydroxy-5-Alpha-Pregnan-20-One for Use in Treatment of Essential Tremor
    Publication number: 20190381069
    Abstract: The present invention provides the steroid compound 3beta-hydroxy-5alpha-pregnan-20-one for use in treatment of essential tremor, as well as methods for treating essential tremor and pharmaceutical compositions for use in treatment of essential tremor.
    Type: Application
    Filed: September 2, 2018
    Publication date: December 19, 2019
    Applicant: ASARINA PHARMA AB
    Inventors: Torbjörn Bäckström, Markus Jerling
  • 3-Beta-Hydroxy-5-Alpha-Pregnan-20-One for Use in Medical Treatment
    Publication number: 20190358245
    Abstract: The present invention provides the steroid compound 3beta-hydroxy-5alpha-pregnan-20-one for use in treatment of Tourette's syndrome, obsessive compulsive disorder and/or gambling disorder, as well as methods for treating said disorders and pharmaceutical compositions for use in treatment of said disorders.
    Type: Application
    Filed: September 2, 2018
    Publication date: November 28, 2019
    Applicant: ASARINA PHARMA AB
    Inventor: Torbjörn Bäckström
  • Injectable Suspensions
    Publication number: 20190350838
    Abstract: The present invention relates to aseptic suspensions, physically stable and injectable through a 25G needle or thinner, comprising crystalline, non-micronized 3-beta-hydroxy-5-alpha-pregnan-20-one particles, a mixture of acylglycerols and cholesterol, processes for preparing crystalline, non-micronized, 3-beta-hydroxy-5-alpha-pregnan-20-one suitable for such suspensions, as well as methods for manufacturing such suspensions.
    Type: Application
    Filed: January 9, 2018
    Publication date: November 21, 2019
    Applicant: ASARINA PHARMA AB
    Inventors: Magnus Brisander, Karol Horvath, Björn Norrlind
  • PHARMACEUTICAL COMPOSITION COMPRISING 3-BETA-HYDROXY-5-ALPHA-PREGNAN-20-ONE WITH IMPROVED STORAGE AND SOLUBILITY PROPERTIES
    Publication number: 20170258809
    Abstract: It is provided a pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one, at least one sterol or an ester thereof and a mixture of acylglycerols with a solid fat content of less than 25% at 25° C. and 0% at 37° C. In addition it is provided a method for preparing the pharmaceutical composition.
    Type: Application
    Filed: May 22, 2017
    Publication date: September 14, 2017
    Applicant: ASARINA PHARMA AB
    Inventors: Torbjörn BÄCKSTRÖM, Anders CARLSSON
  • Pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with improved storage and solubility properties
    Patent number: 9687496
    Abstract: It is provided a pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one, at least one sterol or an ester thereof and a mixture of acylglycerols with a solid fat content of less than 25% at 25° C. and 0% at 37° C. In addition it is provided a method for preparing the pharmaceutical composition.
    Type: Grant
    Filed: February 19, 2015
    Date of Patent: June 27, 2017
    Assignee: ASARINA PHARMA AB
    Inventors: Torbjörn Bäckström, Anders Carlsson